Tender For Supply Of Equipments And Instruments For Pharmacology Department - Archie Oil Shank Pusp Shark Liver Cotton Ashwagandha Tamarind Senna Leaves Brahmi Punarnava Rhubarb Stropanthus Acacia (Indian gum) Neem Oil Turmeric Nux-vomica Black Pepper Opium Jatamansi Cannabis Thats why Arjuna park Valerian Clave bud Linseed Oil Vinca Ginger Nutmeg Cinnamon Digitalis Chaul moogra Ginseng root Eucalyptus Black catechu Garc Peppermint Tulsi Pyrethrum Amla Momordica Hyocyamus LH. Ergot Hem peels Picrorrhiza Cinchona Ipecacuahuan Sandalwood Cardamom Castor oil Ohatura Cassava Kurchi Gokhuru So that Spirulina Citronella Guar gum Pectin Rice bran oil Podophullum Benzoin Caraway Sesame oil Rubber plant Airport Pineapple Indian hemp Oleander Black night Emetic nut Henna Red Chillies Radish Liquorice root Sprout leaf plant Peepal plant Long peeper Indian Mustard Black mustard Prickly poppy Milk bush Sunflower Yeast Chenopodium Shilajit Jalap Baheda Asafoetida Plant something Tragacanth Google Asaka Agaru Jatiphal Karpura Draksha Chandanadvaya Bhallataka Markandika History of Medicine-1 History of Medicine-I History of Medicine-III History of Medicine-V History of Medicine-V History of Medicine-VI History of Medicine-VII History of Medicine Vill History of Medicine-IX History of Medicine-X Dphc 05: Drugs acting on urinary system A. Fluid and electrolyte balance B. Diuretics Dulic 06. Drugs Autocoids A. Histamine, 5HT and their antagonists B. Prostaglandins, thromboxanes and leucotrienes Dphc 41: Metabolism of Plasma Lipoproteins Dphc 51: Pharmacokinetics (A) Routes of Drug administration (B) Absorption of drugs, bioavailability & Drug distribution (C) Binding of Drugs to plasma proteins and Drug metabolism & Drug elimination Dphc 52: Drugs-Receptor interactions and pharmacodynamics Dphc 53: The Autonomic nervous system (A) Introduction, efferent neurons, action of sympathetic and parasympathetic nervous system in effector organs (B) Functions of parasympathetic nervous system, chemical signaling between cells and second messenger system in intracellular response Dphc 55: Cholinergic Antagonists (A) Cholinergic antagonists, site of action of cholinergic antagonists (B) Onset and duration of action of Neuromuscular blocking agents, mechanism of action of depolarizing neuromuscular blocking drugs (C) Dphc 56: Adrenergic agonists (A) Overview, site of action of adrenergic agonists, synthesis and release of norepinephrine from the adrenergic neurons (B) Types of adrenergic receptors, major effects by a and adrenoceptors and structures of important adrenergic agonists (C) Cardiovascular effects of IV of low doses of epinephrine, norepinephrine, isoproterenol, effects of inhaled adrenergic agonists Dphc 57: Adrenergic antagonists (A) Adrenergic blockers, covalent inactivation of a adrenoceptor by phenoxybenzamine, action of propranolol and other B-blockers (B) Comparison of agonists antagonists and partial agonists of B-adrenoceptors, some clinical applications of B-blockers, summery of B-adrenergic antagonists Dphc 59: Arxiolytic and hypnotic drugs (A) Summary of anxiolytic and hypnotic drugs. benzodiazepine, GABA chloride ion channel complex, therapeutic disadvantages and advantages of anxiolytic and hypnotic drugs Dphc 61: Anesthetics, summery of anaesthetics, components of balanced anaesthesia, modulation of a ligand gated membrane channel and therapeutic disadvantages and advantages of some anaesthetic agents Dphc 62: Antidepressant drugs-summery of antidepressants, mechanism of action of SSRI and TCA drugs, mechanism of action of monoamine oxidase inhibitors DPHC 64: Opioid Analgesics and Antagonists: Summery of opioid analgesics, mechanism of action u-opioid receptor, antagonist competition of naloxone with opioid agonists Dphc 66 Treatment of heart failure (A) Summary of drugs used to treat heart failure, physiology of Muscle Contraction, Action potential of a Purkinje fiber (8) lons movements during the contraction of cardiac muscle, cardiovascular consequences of heart failure, effects of angiotensin converting enzyme inhibitors (C) Mechanism of action of cardiac glycosides, ventricular function curves in normal heart, in heart failure, and in HF treated with digitalis, site of action by B-adrenergic agonists on heart muscle Ophc 67: Anti arrhythmic drugs (A) Summary of antiarrhythmic drugs Therapeutic indications of some commonly encountered arrhythmias, schematic representation of reentry (B) Action of antiarrhythmics drugs, schematic diagram of the effects of Class IA, IL, IC agents (C) Schematic diagram of the effects of Class ill and class IV agents Dphc 68: Antianginal drugs: Summary of anti-anginal drugs, summary of nitrates on smooth muscle, blood flow in a coronary artery, partially blocked with atherosclerotic plaques, treatment of angina in patients with concomitant diseases Dphc 69: Antihypertensive Drugs (A) Summary of antihypertensive drugs, major factors influencing blood pressure, response of the autonomic nervous system and the renin-angiotensin system (B) Treatment of hypertension in patients with concomitant diseases, actions of thiazide diuretics, action of B adrenoceptor blocking agents, effects of ACE inhibitors. action of calcium-channel blockers, therapeutic applications of calcium channel blockers DPhc 70: Drugs Affecting the Blood(A) Summary of drugs used in treating dysfunctions of the blood, formation of a hemostatic plug (E)Activation and aggregation of platelets role of mechanism of action of ticlopidine and clopidogrel, aspirin, formation of a fibrin clot, mechanism of action of heparin (C) Mechanism of action of warfarin, drugs affecting the anticoagulant effects of warfarin, mechanism of action of streptokinase, causes and consequences Dphc 71: Antihyperlipidemic Drugs (A) Summary of antihyperlipidemic drugs, metabolism of plasma lipoproteins and related genetic diseases (B) Inhibition of HMG-CoA reductase by the statin drugs, inhibition of lipolysis in adipose tissue by niacin, activation of lipoprotein lipase by gemfibrozit, bile acid-binding resins DPhc 74: Insulin and oral Hypoglycemic Drug (A) Summary of hypoglycemic agenti, comparison of Type 1 and Type 2 diabetes, major factors contributing to hyperglycemia, Duration of type 2 diabetes (8) Onset and duration of action of human insulin and insulin analogs, duration of action of some oral hypoglycemic agents, drugs interacting with sulfonylurea drugs Summary of oral hypoglycemic agents Dphc 77: Drugs affecting the Respiratory system (A) Summary of drugs affecting the respiratory system, Comparison of bronchi of normal and asthmatic individuals. Treatment of asthma. Pharmacokinetics of inhaled glucocorticoids, Effect of spacer on the delivery of inhaled aerosol DPhc 78: Gastrointestinal and Antiemetic Drugs (A) Summary of drugs used to treat peptic ulcer disease, Helicobacter pylori in association with gastric mucosa effects of acetylcholine, histamine, prostaglandin E2. and gastrin on gastrin acid secretion, administration and fate of cimetidine, drug interactions with cimetidine. (B) Comparison of emetic potential of anticancer drugs, summary of drugs used to treat chemotherapy induced nausea and vomiting, potencies of antiemetic drugs, summary of drugs used to treat diarrhea and constipation DPhc 89: Anticancer Drugs (A) Summary, effects of various treatments (8) Effects of chemotherapeutic agents on mammalian cells, mechanism of action of methotrexate (C) Action of 6-mercaptopurine, fate of 6-mercaptopurine action of 5-FU. Fluorouracil, capecitabine (D) Administration and fate of cytarabine, action of gemcitabine, fate of dactinomycin Doxorubicin (E)Alkylation of guanine fate of cyclophosphamide Lomustine, temozolomide. (F) Action of microtubule inhibitors, steroid hormones, (G) Fate of cisplatin action of DNA Topoisomerases Etoposide TYROSINE KINASE RECEPTORS NEUROHORMONAL TRANSMISSION OF ACETYLCHOLINE GABA RECEPTORS SITE OF DRUG ACTION IN GLAUCOMA PAIN PATHWAYS HYPERTENSION CORTICOSTEROID ACTION IN BRONCHIAL ASTHMA ADVERSE EFFECTS
